Translational Genomics and Epigenomics Laboratory

Site

Translational Genomics and Epigenomics Laboratory – MED

Accreditation No.

19912

Site No.

23962

Date of Accreditation

21 Dec 2017

Address

Level 8, Lance Townsend Building, Austin Hospital, 145 Studley Road
Heidelberg, VIC 3084
Australia

mdhs.unimelb.edu.au/centre-for-cancer-research

Contact

Prof Alexander Dobrovic P: +61 (03) 94965494

Availability

Services available to external clients

Supervision

Not Applicable

Scope of Accreditation

Print scopes
Translational Genomics and Epigenomics Laboratory – MED

ISO 15189 (2022)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes Blood; Formalin-fixed paraffin-embedded (FFPE) tissues Blood borne tumours; Breast cancer; Solid tumours
Molecular genetics - DNA extraction Blood; Formalin-fixed paraffin-embedded (FFPE) tissues Viable DNA; Viable DNA for sequencing
Molecular genetics - Detection and characterisation of cell free RNA (cfRNA)/cell free DNA (cfDNA) in cancer screening and/or cancer genetic testing Blood Nucleic acid analysis for specific variants
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes Blood; Formalin-fixed paraffin-embedded (FFPE) tissues BRCA1 methylation; Blood borne tumours; Inherited cancer syndromes; Nucleic acid analysis for specific variants; Solid tumours

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.